A team from Stanford University School of Medicine has developed and combined new paper and flexible polymer substrates with special sensing devices for rapid and accurate detection of pathogens such as HIV and other biotargets. These novel technologies offer the type of robust, simple, and inexpensive biosensing systems required to provide point-of-care healthcare in remote areas, where there is minimal diagnostic infrastructure or equipment and a lack of trained medical technicians.
Cardiovascular Systems Inc. (CSI) featured two-year data from its ORBIT II study of the company’s Diamondback 360 coronary orbital atherectomy system (OAS) in a late-breaking presentation at the 2015 Society for Cardiovascular Angiography and Interventions (SCAI) conference. Diamondback 360 is a U.S. Food and Drug Administration (FDA)-approved atherectomy technology indicated for the treatment of severely calcified lesions.
CardiAQ Valve Technologies announced U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval for a feasibility study of its second generation transfemoral (TF) and transapical (TA) transcatheter mitral valve implantation systems. The study will enroll up to 20 patients (10 TF and 10 TA) and multidisciplinary physician teams at select U.S. sites will start enrollment once hospital approvals and agreements are in place.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Spok Inc. announced the availability of message notifications on the Apple Watch wrist wearable device to enable clinicians to enhance care coordination. The Spok Mobile secure texting app is currently used by numerous hospitals to give users quick access to the organization’s directory, allowing staff to communicate securely through encrypted text, image and video messages. In addition, the app can receive alerts from patient care, nurse call and other monitoring systems to speed response to critical situations.
While demand for electrocardiogram (ECG) monitoring systems is increasing, a major hurdle has been the necessity of gel electrodes for reliable long-term measurements. The electrodes dry out within 24 hours, after which they no longer produce useable signals. They are also not very suitable for older patients who frequently sweat less and are less mobile than younger subjects. A team of Swiss researchers, however, recently unveiled a new chest strap heart rate monitor featuring wettable electrodes.
May 11, 2015 — The Heart Rhythm Society (HRS) has released the list of its 12 late-breaking electrophysiology (EP) clinical trials that will be presented at Heart Rhythm 2015, which takes place May 13-16, 2015 in Boston.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Medtronic plc announced it has received CE (Conformité Européenne) Mark for the Micra Transcatheter Pacing System (TPS), the world’s smallest pacemaker. At less than one-tenth the size of traditional pacemakers, the Micra device provides advanced pacing technology while being cosmetically invisible and small enough to be delivered with minimally invasive techniques through a catheter, and implanted directly into the heart.
Boston Scientific Corp. presented an overview of its continued business momentum and long-term growth strategies at a meeting with the investment community May 1.
The ScottCare Corp. announced it will highlight Ambucor, the company’s employable labor service division for CIED monitoring, at the 2015 Heart Rhythm Society Scientific Sessions in Boston, May 13-16.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
As the use of point-of-care (POC) ultrasound continues to expand throughout hospitals and clinics, the ECRI Institute has released a new guide to the modality for practitioners. The document explains the difference between POC and traditional ultrasound, the different types of POC ultrasound units and the numerous applications for the technology.
While the human heart can’t heal itself, the zebrafish heart can easily replace cells lost by damage or disease. Now, researchers have discovered properties of a mysterious outer layer of the heart known as the epicardium that could help explain the fish’s remarkable ability to regrow cardiac tissue.
Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. launch of the Euphora Semicompliant Balloon Dilatation Catheter. Euphora is a pre-dilatation therapy used during a stent implantation to reopen a narrowed coronary artery caused by plaque buildup.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Pie Medical Imaging announces its new release of 3mensio Structural Heart, dedicated to planning of structural heart interventions. This new release contains an optimized Mitral workflow and a new Septal Crossing workflow for planning of mitral valve procedures to determine the appropriate access route based on computed tomography (CT) images. These new innovations will be shown at the EuroPCR in Paris, May 19- 22.
Gene therapy can clip out genetic material linked to heart failure and replace it with normal genes, according to a study from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai. The study is published in the April 29 edition of Nature Communications.
New technology developed at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH) may extend the benefits of magnetic resonance imaging (MRI) to many patients whose access to MRI is currently limited. A redesign of the wire at the core of the leads carrying signals between implanted medical devices and their target structures significantly reduces the generation of heat that occurs when standard wires are exposed to the radiofrequency (RF) energy used in MRI. The novel system is described in a paper published in the online Nature journal Scientific Reports.
May 12, 2015
